Targeted mass spectrometry (MS) has become a central technique in translational biology, bridging fundamental discovery work and real-world clinical validation. By allowing precise quantification of specific proteins, peptides, and metabolites, targeted MS helps answer critical biological questions, especially in metabolic and lifestyle diseases like diabetes.
From the "Only One Analytical Technique" talk series by Venture Center. Watch the full video here -
This article sheds light on how well-designed targeted assays can reveal early biochemical changes long before conventional clinical markers show deviations. It highlights real-world challenges, where conventional biochemical assays fall short due to limited sensitivity or lack of molecular specificity. In contrast, targeted MS workflows—especially MRM and PRM—enable researchers to quantify subtle biochemical modifications at the peptide level with high accuracy and reproducibility.
Targeted Mass Spectrometry Quantification Techniques: MRM vs PRM
Two core methods dominate targeted proteomics:
- Multiple Reaction Monitoring (MRM): Conducted on triple quadrupole instruments, MRM tracks specific precursor and fragment ion pairs (transitions). Known for its sensitivity and reproducibility, it remains the gold standard for quantitative analysis.
- Parallel Reaction Monitoring (PRM): Used on Orbitrap or TOF platforms, PRM captures all fragment ions from a precursor with high resolution, enhancing specificity and simplifying data acquisition.
These targeted methods are vital when commercial antibodies are unavailable or when multiple analytes must be quantified simultaneously.
Targeted Mass Spectrometry Workflow: From Discovery to Clinical Validation
Untargeted Mass Spectrometry explores wide biomolecular landscapes for discovery, while targeted mass spectrometry confirms and quantifies specific markers across large sample sets. For example:
- Discovery: Identify potential biomarkers using untargeted MS.
- Validation: Quantify confirmed biomarkers via MRM/PRM in patient cohorts.
This pipeline bridges discovery and clinical validation, making translational research faster and more reproducible.
Case Study: Tracking Protein Glycation in Diabetes using Targeted Mass Spectrometry
Protein glycation—a hallmark of diabetes—occurs when glucose reacts non-enzymatically with proteins. The study team leveraged Orbitrap-based PRM and MRM workflows to measure glycated proteins like albumin and insulin, generating highly reproducible and diagnostic data.
Key Findings:
- Built a mass spectral library of glycated peptides.
- Identified glycation-sensitive sites (e.g., K36, K438, K549) on albumin.
- Quantified these peptides in healthy vs pre-diabetic samples, showing superior early diagnostic accuracy over HbA1c.
- Linked glycated insulin to insulin resistance and inflammation.
These results demonstrate the ability of targeted MS to uncover molecular changes invisible to traditional assays.
Targeted Metabolomics Using Mass Spectrometry
Targeted metabolomics complements proteomics by focusing on disease-linked metabolites. The approach enabled quantification of glycated urea, a promising biomarker for diabetic nephropathy.
Highlights:
- Built a spectral library of glycated amines and metabolites.
- Used isotopic labeling (12C/13C glucose) to confirm fragmentation patterns.
- Quantified mono- and diglycated urea in clinical samples.
- Observed a strong correlation with HbA1c and fasting glucose levels.
Benefits of Targeted Mass Spectrometry in Translational Research
- Enables absolute quantification without antibodies.
- Allows multi-analyte analysis in one run.
- Reduces variability compared to ELISA or Western blot.
- Streamlines biomarker validation for clinical translation.
CAMS at Venture Center: Your Partner in Targeted Mass Spectrometry
CAMS at Venture Center provides GLP- and NABL-compliant targeted MS capabilities, equipped with advanced Orbitrap, Q-TOF, and Triple Quadrupole instruments.
It supports:
- Targeted quantification of proteins, peptides, and metabolites
- MRM and PRM method development and validation
- Mass spectral library construction
- Training and technical consultation for bio-pharma innovators
Reach out to CAMS at Venture Center, NCL Innovation Park, Pune to get started.
Email - rutuja.patil@venturecenter.co.in
Learn more at - https://www.venturecenter.co.in/services/analytical-measurements-and-certifications/mass-spectrometry-services
Book our mass spectrometry services today - https://tinyurl.com/ffdz2nam